Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with breast cancer

Abstract

Adjuvant chemotherapy may contribute to an increased risk for metabolic syndrome in patients with BC and these changes are more profound in pre-menopausal patients.